Computational reconstruction of Bole1a, a representative synthetic hepatitis C virus subtype 1a genome
Journal of virology, 2012•Am Soc Microbiol
Hepatitis C virus (HCV) research is hampered by the use of arbitrary representative isolates
in cell culture and immunology. The most replicative isolate in vitro is a subtype 2a virus
(JFH-1); however, genotype 1 is more prevalent worldwide and represents about 70% of
infections in the United States, and genotypes differ from one another by 31% to 33% at the
nucleotide level. For phylogenetic and immunologic analyses, viruses H77 and HCV-1 (both
subtype 1a) are commonly used based on their historic importance. In an effort to rationally …
in cell culture and immunology. The most replicative isolate in vitro is a subtype 2a virus
(JFH-1); however, genotype 1 is more prevalent worldwide and represents about 70% of
infections in the United States, and genotypes differ from one another by 31% to 33% at the
nucleotide level. For phylogenetic and immunologic analyses, viruses H77 and HCV-1 (both
subtype 1a) are commonly used based on their historic importance. In an effort to rationally …
Abstract
Hepatitis C virus (HCV) research is hampered by the use of arbitrary representative isolates in cell culture and immunology. The most replicative isolate in vitro is a subtype 2a virus (JFH-1); however, genotype 1 is more prevalent worldwide and represents about 70% of infections in the United States, and genotypes differ from one another by 31% to 33% at the nucleotide level. For phylogenetic and immunologic analyses, viruses H77 and HCV-1 (both subtype 1a) are commonly used based on their historic importance. In an effort to rationally design a representative subtype 1a virus (Bole1a), we used Bayesian phylogenetics, ancestral sequence reconstruction, and covariance analysis on a curated set of 390 full-length human HCV 1a sequences from GenBank. By design, Bole1a contains variations present in widely circulating strains and matches more epitope-sized peptides in a full-genome comparison to subtype 1a isolates than any other sequence studied. Parallel analyses confirm that selected epitopes from the Bole1a genome were able to elicit a robust T cell response. In a proof of concept for infectivity, the envelope genes (E1 and E2) of Bole1a were expressed in an HIV pseudoparticle system containing HCV envelope genes and HIV nonenvelope genes with luciferase expression. The resulting Bole1a pseudoparticle robustly infected Hep3B cells. In this study, we demonstrate that a rationally designed, fully synthetic HCV genome contains representative epitopes and envelope genes that assemble properly and mediate entry into target cells.
![](/scholar/images/qa_favicons/asm.org.png)